aluminum sulfate has been researched along with lipid a in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 16 (59.26) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Abeles, G; Bystryn, JC; Chen, D; Oratz, R; Schultz, N; Zeleniuch-Jacquotte, A | 1 |
| Alving, CR; Richards, RL; Wassef, NM | 1 |
| Brennan, FR; Dimmock, NJ; Jones, TD; McInerney, TL | 1 |
| Ambrosch, F; Desombere, I; Garcon, N; Kundi, M; Leroux-Roels, G; Slaoui, M; Thiriart, C; Thoelen, S; Wiedermann, G | 1 |
| Coutelier, JP; Gómez, KA; Longhi, SA; Loureiro, ME; Marino, VJ; Mathieu, PA; Retegui, LA; Roguin, LP | 1 |
| Batzloff, MR; Brandt, ER; Davies, MR; Good, MF; Hayman, WA; Pruksakorn, S; Zeng, M | 1 |
| Durham, SR; Francis, JN | 1 |
| Bernstein, D | 1 |
| Barnwell, JW; Collins, WE; Galland, GG; Lal, AA; Nace, D; Roberts, J; Shi, YP; Sullivan, JS; Tongren, JE; Udhayakumar, V; Williams, T | 1 |
| Cease, KB; Hankenson, FC; Oscherwitz, J; Yu, F | 1 |
| Bemark, M; Bergqvist, P; Holmberg, A; Lycke, NY; Mattsson, J; Stensson, A | 1 |
| Kraynyak, KA; Levinson, MS; Morello, CS; Spector, DH | 1 |
| David, A; Kappler, JW; MacLeod, MK; Marrack, P; Mason, R; McKee, AS; Wang, J | 1 |
| Bright, H; Chappell, D; Christy, C; Cockle, P; Evans, DM; Eyles, J; Gore, K; Hammond, D; Khodai, T; Lang, S; Loudon, PT; McCluskie, MJ; Townend, T; West, K; Wright, P | 1 |
| Chen, Z; Kraynyak, KA; Lee, KF; Levinson, MS; Morello, CS; Spector, DH | 1 |
| Kaur, H; Kaur, S; Thakur, A | 1 |
| Bogans, J; Dekhtyar, Y; Dishlers, A; Lieknina, I; Ose, V; Petrovskis, I; Pumpens, P; Renhofa, R; Skrastina, D | 1 |
| Agnolon, V; Baudner, BC; Bruno, C; D'Oro, U; Galletti, B; Leuzzi, R; O'Hagan, DT; Pizza, M; Seubert, A | 1 |
| Huo, Y; Ling, T; Meng, S; Shen, S; Wan, X; Wang, Z; Wu, J | 1 |
| Ahmed, S; Bergelson, I; Berger, ST; Brightman, S; Choi, H; Dowling, DJ; Kho, AT; Levy, O; Oh, DY; Pettengill, M; Pollack, HJ; Sauld, JF; Steen, H | 1 |
| Jonsdottir, S; Marti, E; Rhyner, C; Schüpbach, G; Stefansdottir, SB; Svansson, V; Torsteinsdottir, S | 1 |
| Cong, H; Guo, J; Han, Y; Hao, Z; He, S; Lv, G; Song, P; Zhou, A; Zhou, H; Zhou, J | 1 |
| Bennett, AS; Cayatte, C; Cheng, L; Hostetler, L; McCarthy, MP; McTamney, P; Nacel, K; O'Day, T; Prince, GA; Rajani, GM; Ren, K; Schneider-Ohrum, K | 1 |
| Casella, CR; Mitchell, TC | 1 |
| Ahmad, G; Carter, D; Kim, E; Lazarus, S; Le, L; Molehin, AJ; Siddiqui, AA; Siddiqui, AJ; Torben, W; Zhang, W | 1 |
| Hwang, HS; Jeeva, S; Jung, YJ; Kang, SM; Kim, KH; Ko, EJ; Kwon, YM; Lee, Y; Lee, YT; Seong, BL | 1 |
| Abparvar, AA; Ahmadi, K; Davoodian, P; Eftekhar, E; Einakian, MA; Faezi, S; Ghaedi, T; Hassaniazad, M | 1 |
4 review(s) available for aluminum sulfate and lipid a
| Article | Year |
|---|---|
Liposomes as carriers for vaccines.
Topics: Adjuvants, Immunologic; AIDS Vaccines; Alum Compounds; Animals; Clinical Trials as Topic; Drug Compounding; Haplorhini; Humans; Injections, Intramuscular; Injections, Intravenous; Lipid A; Liposomes; Malaria Vaccines; Mice; Plasmodium falciparum; Quality Control; Rabbits; Safety; SAIDS Vaccines; Vaccination; Vaccines | 1994 |
Adjuvants for allergen immunotherapy: experimental results and clinical perspectives.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Bacterial Vaccines; Desensitization, Immunologic; Humans; Lipid A; Mycobacterium; Respiratory Hypersensitivity; Vaccines, DNA | 2004 |
Glycoprotein D adjuvant herpes simplex virus vaccine.
Topics: Adjuvants, Immunologic; Adolescent; Alum Compounds; Animals; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Herpes Genitalis; Herpes Simplex Virus Vaccines; Humans; Lipid A; Male; Vaccination; Viral Envelope Proteins | 2005 |
No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.
Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Viral; Diphtheria-Tetanus-acellular Pertussis Vaccines; Drug-Related Side Effects and Adverse Reactions; Humans; Lipid A; Pain; Papillomavirus Infections; Papillomavirus Vaccines; Toll-Like Receptor 4; Treatment Outcome; Vaccination; Whooping Cough | 2017 |
2 trial(s) available for aluminum sulfate and lipid a
| Article | Year |
|---|---|
Effect of DETOX as an adjuvant for melanoma vaccine.
Topics: Adjuvants, Immunologic; Adult; Aged; Alum Compounds; Antibodies, Neoplasm; Antigens, Neoplasm; Cell Wall Skeleton; Drug Synergism; Female; Humans; Hypersensitivity, Delayed; Lipid A; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins | 1995 |
A hepatitis B vaccine formulated with a novel adjuvant system.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Double-Blind Method; Edema; Fatigue; Female; Follow-Up Studies; Headache; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunity, Cellular; Immunization, Secondary; Lipid A; Lymphocyte Activation; Male; Pain; Safety; Seroepidemiologic Studies; Vaccines, Synthetic | 2000 |
21 other study(ies) available for aluminum sulfate and lipid a
| Article | Year |
|---|---|
Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Cell Wall Skeleton; Chimera; Comovirus; Cord Factors; Freund's Adjuvant; HIV Envelope Protein gp41; Immunization, Secondary; Lipid A; Mice; Quillaja Saponins; Recombinant Fusion Proteins; Saponins; T-Lymphocytes; Viral Vaccines | 1999 |
Effects of various adjuvants and a viral infection on the antibody specificity toward native or cryptic epitopes of a protein antigen.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Antibody Specificity; Arterivirus Infections; Autoantibodies; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Freund's Adjuvant; Human Growth Hormone; Kidney; Lactate dehydrogenase-elevating virus; Lipid A; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Muscles; Myocardium | 2003 |
Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Diphtheria Toxoid; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Lipid A; Male; Mice; Saponins; Streptococcal Infections; Streptococcus; Survival Rate; T-Lymphocytes; Time Factors; Vaccines, Conjugate | 2003 |
Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Aotidae; Disease Models, Animal; Drug Combinations; Female; Freund's Adjuvant; Hematocrit; Immunization Schedule; Lipid A; Malaria Vaccines; Malaria, Falciparum; Male; Plasmodium falciparum; Polymers; Saponins; Treatment Outcome; Vaccines, Synthetic | 2005 |
Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
Topics: Adjuvants, Immunologic; Alum Compounds; Alzheimer Vaccines; Amyloid beta-Peptides; Animals; Antibodies; Body Weight; Cord Factors; Female; Freund's Adjuvant; Injections, Intraperitoneal; Leukocyte Count; Lipid A; Mice; Mice, Inbred C57BL; Models, Animal; Spleen | 2006 |
A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; B-Lymphocyte Subsets; Cell Differentiation; Cell Wall Skeleton; Cholera Toxin; Cord Factors; Dose-Response Relationship, Immunologic; Female; Germinal Center; Immunoglobulin A; Immunoglobulin G; Immunologic Memory; Lipid A; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Plasma Cells; Recombinant Fusion Proteins; Time Factors | 2011 |
Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; DNA, Viral; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Immunization, Secondary; Lipid A; Secondary Prevention; Vaccination; Vaccines, DNA; Vaccines, Inactivated | 2011 |
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigen Presentation; Antigens, Surface; Apoptosis Regulatory Proteins; Cattle; Cytokines; Female; Humans; Immunologic Memory; Influenza A virus; Interleukin-6; Lipid A; Mice; Mice, Knockout; Mice, Transgenic; Nucleocapsid Proteins; Orthomyxoviridae Infections; Ovalbumin; Programmed Cell Death 1 Receptor; RNA-Binding Proteins; Serum Albumin, Bovine; T-Lymphocytes, Cytotoxic; Vaccines, Subunit; Viral Core Proteins | 2011 |
Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Disease Models, Animal; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Interferon-gamma; Lipid A; Mice; Oligodeoxyribonucleotides; Severity of Illness Index; T-Lymphocytes; Viral Envelope Proteins | 2011 |
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens, Viral; Disease Models, Animal; Female; Ganglia, Spinal; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Lipid A; Mice; Mice, Inbred BALB C; Survival Analysis; Vaccination; Vaccines, DNA; Vagina; Virus Shedding | 2012 |
Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cytokines; Female; Hypersensitivity, Delayed; Immunity, Humoral; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Mice; Mice, Inbred BALB C; Parasite Load; Saponins; Vaccination; Vaccines, Inactivated | 2015 |
Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Female; Freund's Adjuvant; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Vaccines; Hepatitis B virus; Immunity, Humoral; Immunization; Lipid A; Lipids; Mice, Inbred BALB C; Nanoparticles; Silicon Dioxide | 2014 |
The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bordetella pertussis; Cell Line, Tumor; Chlorocebus aethiops; CHO Cells; Cricetulus; Diphtheria Toxin; Diphtheria-Tetanus-Pertussis Vaccine; Female; Humans; Immunoglobulin G; Lipid A; Mice; Mice, Inbred BALB C; Pertussis Toxin; Polysorbates; Squalene; Vero Cells | 2015 |
Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Baculoviridae; Caliciviridae Infections; Cholera Toxin; Female; Gene Expression; Humans; Immunity, Mucosal; Immunization; Lipid A; Mice; Mice, Inbred BALB C; Norovirus; Recombinant Proteins; Sf9 Cells; Spodoptera; Vaccines, Virus-Like Particle; Viral Vaccines; Virion | 2015 |
Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures.
Topics: Adjuvants, Immunologic; Adult; Age Factors; Alum Compounds; Chromatography, Liquid; Humans; Imidazoles; Immunity, Innate; Infant, Newborn; Lipid A; Mass Spectrometry; Monocytes; Proteome; Proteomics | 2016 |
A preventive immunization approach against insect bite hypersensitivity: Intralymphatic injection with recombinant allergens in Alum or Alum and monophosphoryl lipid A.
Topics: Allergens; Alum Compounds; Animals; Ceratopogonidae; Cytokines; Dermatitis; Horse Diseases; Horses; Hypersensitivity; Immunoglobulin E; Injections, Intralymphatic; Insect Bites and Stings; Insect Proteins; Lipid A; Vaccination; Vaccines, Synthetic | 2016 |
Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
Topics: Actin Capping Proteins; Adjuvants, Immunologic; Alum Compounds; Animals; Antibody Formation; Female; Immunity, Cellular; Lipid A; Mice, Inbred BALB C; Protozoan Proteins; Protozoan Vaccines; Toxoplasma; Toxoplasmosis; Vaccines, DNA | 2017 |
Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antibody-Dependent Enhancement; Disease Models, Animal; Lipid A; Recombinant Proteins; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Sigmodontinae; Th1 Cells; Th2 Cells; Vaccines, Synthetic; Viral Fusion Proteins | 2017 |
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens, Helminth; Cell Proliferation; Cytokines; Female; Glucosides; Immunity, Humoral; Lipid A; Mice, Inbred C57BL; Papio; Recombinant Proteins; RNA, Messenger; Schistosoma mansoni; Schistosomiasis mansoni; T-Lymphocytes, Helper-Inducer; Toll-Like Receptor 4; Vaccination; Vaccines | 2018 |
The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Cell Line; Humans; Immunoglobulin G; Lipid A; Lung; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Th1 Cells; Vaccines, Inactivated; Viral Load | 2019 |
Protective efficacy of Hla-MntC-SACOL0723 fusion protein adjuvanted in alum and MPL against Staphylococcus aureus sepsis infection in mice.
Topics: Alum Compounds; Animals; Female; HLA Antigens; Immunoglobulin G; Interleukin-17; Interleukin-4; Kidney; Lipid A; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Periplasmic Binding Proteins; Recombinant Fusion Proteins; Sepsis; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus aureus; Up-Regulation | 2021 |